Use of immune checkpoint inhibitors in cancer patients with pre-existing sarcoidosis

AIM: To evaluate adverse events in cancer patients with pre-existing sarcoidosis receiving immune checkpoint inhibitors (ICIs). PATIENTS & METHODS: We retrospectively reviewed cancer patients with sarcoidosis who underwent treatment with ICI to determine frequency of sarcoidosis flares. RESULTS:...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Immunotherapy
Päätekijät: Kim, Sang T, Pundole, Xerxes, Dadu, Ramona, Lambotte, Olivier, Ramos-Casals, Manuel, Suarez-Almazor, Maria E
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Future Medicine Ltd 2021
Aiheet:
Case Series
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7983044/
https://ncbi.nlm.nih.gov/pubmed/33641345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt-2020-0272
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia